Skip to content
2000
Volume 6, Issue 5
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Drugs that block the entry of human immunodeficiency virus type 1 (HIV-1) into host cells abrogate the establishment of a productive infection and should ideally diminish the chances of HIV-1 developing resistance. This review will give an overview of the mechanism by which the envelope glycoprotein mediates HIV-1 entry and will summarize current drug developments.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955706776876267
2006-05-01
2025-06-21
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955706776876267
Loading

  • Article Type:
    Research Article
Keyword(s): entry; HIV; inhibitor
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test